Semi-Annual Statement Of Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7585748

Concept 2022-04-01 to
2022-09-30
2021-04-01 to
2021-09-30
Semi-annual statement of income
Statement of income
Net sales
25,371,000,000 JPY
24,966,000,000 JPY
Cost of sales
18,328,000,000 JPY
18,187,000,000 JPY
Ordinary profit (loss)
1,399,000,000 JPY
1,353,000,000 JPY
Gross profit (loss)
7,042,000,000 JPY
6,779,000,000 JPY
Selling, general and administrative expenses
5,757,000,000 JPY
5,525,000,000 JPY
Extraordinary losses
7,000,000 JPY
5,000,000 JPY
Selling, general and administrative expenses
Salaries
1,215,000,000 JPY
1,217,000,000 JPY
Depreciation
221,000,000 JPY
228,000,000 JPY
Profit (loss) before income taxes
1,391,000,000 JPY
1,347,000,000 JPY
Operating profit (loss)
1,285,000,000 JPY
1,253,000,000 JPY
Income taxes - current
329,000,000 JPY
163,000,000 JPY
Non-operating income
296,000,000 JPY
255,000,000 JPY
Income taxes - deferred
44,000,000 JPY
140,000,000 JPY
Non-operating income
Income taxes
373,000,000 JPY
303,000,000 JPY
Non-operating expenses
182,000,000 JPY
156,000,000 JPY
Profit (loss)
1,018,000,000 JPY
1,043,000,000 JPY
Non-operating expenses
Interest expenses
82,000,000 JPY
88,000,000 JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.